ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/11/10 | 1,720 | 1,737 | 1,683 | 1,730 | +112 | +6.9% | 110,100 |
2016/11/09 | 1,703 | 1,720 | 1,604 | 1,618 | -72 | -4.3% | 126,500 |
2016/11/08 | 1,711 | 1,711 | 1,681 | 1,690 | -6 | -0.4% | 56,800 |
2016/11/07 | 1,737 | 1,737 | 1,681 | 1,696 | +26 | +1.6% | 125,800 |
2016/11/04 | 1,684 | 1,694 | 1,653 | 1,670 | -34 | -2% | 93,100 |
2016/11/02 | 1,744 | 1,744 | 1,692 | 1,704 | -52 | -3% | 87,000 |
2016/11/01 | 1,761 | 1,761 | 1,741 | 1,756 | -6 | -0.3% | 80,000 |
2016/10/31 | 1,734 | 1,767 | 1,708 | 1,762 | +20 | +1.1% | 195,000 |
2016/10/28 | 1,769 | 1,774 | 1,741 | 1,742 | -14 | -0.8% | 182,000 |
2016/10/27 | 1,767 | 1,767 | 1,738 | 1,756 | -5 | -0.3% | 86,400 |
2016/10/26 | 1,749 | 1,764 | 1,737 | 1,761 | +20 | +1.1% | 113,900 |
2016/10/25 | 1,751 | 1,753 | 1,738 | 1,741 | -8 | -0.5% | 80,000 |
2016/10/24 | 1,725 | 1,756 | 1,720 | 1,749 | +30 | +1.7% | 113,200 |
2016/10/21 | 1,729 | 1,729 | 1,715 | 1,719 | -5 | -0.3% | 79,300 |
2016/10/20 | 1,727 | 1,729 | 1,711 | 1,724 | -2 | -0.1% | 96,300 |
2016/10/19 | 1,734 | 1,739 | 1,721 | 1,726 | -8 | -0.5% | 58,400 |
2016/10/18 | 1,718 | 1,738 | 1,717 | 1,734 | +8 | +0.5% | 87,700 |
2016/10/17 | 1,728 | 1,731 | 1,707 | 1,726 | -10 | -0.6% | 82,000 |
2016/10/14 | 1,738 | 1,747 | 1,735 | 1,736 | -10 | -0.6% | 58,500 |
2016/10/13 | 1,745 | 1,746 | 1,719 | 1,746 | ±0 | ±0% | 65,600 |
2016/10/12 | 1,737 | 1,759 | 1,728 | 1,746 | -11 | -0.6% | 72,500 |
2016/10/11 | 1,757 | 1,759 | 1,744 | 1,757 | -5 | -0.3% | 74,800 |
2016/10/07 | 1,776 | 1,778 | 1,757 | 1,762 | -14 | -0.8% | 90,900 |
2016/10/06 | 1,780 | 1,787 | 1,772 | 1,776 | +3 | +0.2% | 135,800 |
2016/10/05 | 1,748 | 1,782 | 1,735 | 1,773 | +30 | +1.7% | 219,400 |
2016/10/04 | 1,735 | 1,750 | 1,708 | 1,743 | +13 | +0.8% | 149,700 |
2016/10/03 | 1,718 | 1,741 | 1,711 | 1,730 | +24 | +1.4% | 125,800 |
2016/09/30 | 1,677 | 1,715 | 1,669 | 1,706 | -10 | -0.6% | 109,500 |
2016/09/29 | 1,702 | 1,720 | 1,688 | 1,716 | +32 | +1.9% | 162,500 |
2016/09/28 | 1,682 | 1,687 | 1,544 | 1,684 | -32 | -1.9% | 176,700 |
2016/09/27 | 1,670 | 1,717 | 1,658 | 1,716 | +45 | +2.7% | 341,300 |
2016/09/26 | 1,675 | 1,690 | 1,668 | 1,671 | +1 | +0.1% | 126,300 |
2016/09/23 | 1,648 | 1,675 | 1,636 | 1,670 | +40 | +2.5% | 157,400 |
2016/09/21 | 1,610 | 1,631 | 1,602 | 1,630 | +22 | +1.4% | 135,200 |
2016/09/20 | 1,598 | 1,617 | 1,577 | 1,608 | +1 | +0.1% | 139,100 |
2016/09/16 | 1,598 | 1,607 | 1,580 | 1,607 | +25 | +1.6% | 146,600 |
2016/09/15 | 1,562 | 1,608 | 1,539 | 1,582 | +55 | +3.6% | 269,600 |
2016/09/14 | 1,520 | 1,544 | 1,514 | 1,527 | ±0 | ±0% | 46,700 |
2016/09/13 | 1,539 | 1,539 | 1,516 | 1,527 | ±0 | ±0% | 44,400 |
2016/09/12 | 1,530 | 1,541 | 1,516 | 1,527 | -10 | -0.7% | 45,100 |
2016/09/09 | 1,551 | 1,562 | 1,531 | 1,537 | -10 | -0.6% | 78,600 |
2016/09/08 | 1,537 | 1,551 | 1,529 | 1,547 | +15 | +1% | 64,100 |
2016/09/07 | 1,516 | 1,535 | 1,507 | 1,532 | +16 | +1.1% | 50,200 |
2016/09/06 | 1,508 | 1,519 | 1,493 | 1,516 | +9 | +0.6% | 41,400 |
2016/09/05 | 1,510 | 1,510 | 1,489 | 1,507 | +14 | +0.9% | 41,900 |
2016/09/02 | 1,485 | 1,500 | 1,477 | 1,493 | +9 | +0.6% | 40,600 |
2016/09/01 | 1,470 | 1,485 | 1,456 | 1,484 | +21 | +1.4% | 65,600 |
2016/08/31 | 1,501 | 1,503 | 1,438 | 1,463 | -38 | -2.5% | 136,800 |
2016/08/30 | 1,497 | 1,507 | 1,491 | 1,501 | -5 | -0.3% | 35,400 |
2016/08/29 | 1,518 | 1,541 | 1,498 | 1,506 | +18 | +1.2% | 52,400 |
2151~
2200
件表示中 / 3772件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,000円 | +3.1% | -6.5% | 2.36% | 9.42倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 312,500円 | +5.1% | -7.0% | 2.56% | 20.51倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,300円 | +4.1% | -3.1% | 2.35% | 21.48倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 151,400円 | -2.4% | -52.3% | 3.76% | 18.12倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム